1. Home
  2. NSSC vs EVO Comparison

NSSC vs EVO Comparison

Compare NSSC & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NAPCO Security Technologies Inc.

NSSC

NAPCO Security Technologies Inc.

HOLD

Current Price

$37.04

Market Cap

1.6B

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.57

Market Cap

994.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSSC
EVO
Founded
1969
1993
Country
United States
Germany
Employees
N/A
4553
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
994.5M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
NSSC
EVO
Price
$37.04
$2.57
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
1
Target Price
$48.17
$7.00
AVG Volume (30 Days)
373.0K
28.6K
Earning Date
05-04-2026
04-08-2026
Dividend Yield
1.33%
N/A
EPS Growth
N/A
N/A
EPS
0.70
N/A
Revenue
$181,621,000.00
N/A
Revenue This Year
$13.63
$1.37
Revenue Next Year
$10.05
$10.05
P/E Ratio
$53.81
N/A
Revenue Growth
N/A
N/A
52 Week Low
$29.27
$2.31
52 Week High
$47.61
$4.42

Technical Indicators

Market Signals
Indicator
NSSC
EVO
Relative Strength Index (RSI) 50.26 37.20
Support Level $34.77 $2.32
Resistance Level $38.07 $3.82
Average True Range (ATR) 1.26 0.07
MACD 0.40 -0.03
Stochastic Oscillator 74.77 0.00

Price Performance

Historical Comparison
NSSC
EVO

About NSSC NAPCO Security Technologies Inc.

NAPCO Security Technologies Inc manufactures security products, encompassing access control systems, door-locking products, intrusion and fire alarm systems and video surveillance products. Its products are used for various applications which includes alarm systems like automatic communicators, combination control panels/digital communicators and digital keypad systems, fire alarm control panel and area detectors mainly used for commercial, residential, institutional, industrial and governmental uses. Geographically, the company derives a majority of its revenue from the United States.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: